7 Hills Pharma, LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy (NCT06362369) | 7 Hills Pharma, LLC | 2024-08-23 |
| A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects (NCT04508179) | 7 Hills Pharma, LLC | 2020-10-28 |
Track 7 Hills Pharma, LLC automatically
Every clearance here is in the API, with alerts when new ones post.